Fenbendazole – an antiparasitic drug has been used to treat parasitic worm infestations in animals since the 70s.
On the other hand, fenbendazole has been shown to be particularly successful as a therapy of various aggressive malignancies in people. Fenbendazole has a number of advantages above and beyond the usual cancer-fighting methods, including these:
- Many studies have shown that it is a successful treatment for certain aggressive malignancies in people.
For example, patients with DLBCL (diffuse large B-cell lymphoma), renal, bladder and metastatic cancers may benefit with Fenbendazole alone, according to one study.
- In terms of adverse effects, fenbendazole has none and is safe for people to use.
- There are numerous nations where you may buy it over-the-counter..
- Its production costs are quite low.
In addition, how fenbendazole works is explained in this article. We found that the anticancer effect of fenbendazole was extremely comparable to that of Taxol, another anticancer drug regarded as a plant alkaloid. Furthermore, fenbendazole’s toxicity is significantly lower than that reported with traditional chemotherapies because of the drug’s unique mechanism of action and remarkable safety profile. Some malignancies may be linked to and driven by parasites, and the like, as shown by many observations and studies (as well as the appearance of particular patterns).
If the cancer cells find themselves in fruitful conditions, symbolized by a damaged immune system and certain genetic changes, it’s likely that this is the case in many more cases than we are aware of.
The usage of anthelmintic drugs and other medications as a component of cancer therapy strategy that also includes conventional cancer treatments is something that we take very seriously.
Fenbendazole for humans
Unlike mebendazole, fenbendazole is seldom prescribed to people for medical reasons. To combat parasitic worms, such as various tape worms, whip worm, hookworm, and roundworm, fenbendazole is often used in the treatment of animals.
The anti-cancer drug fenbendazole, marketed under trade names like Panacur and Safe-Guard, was originally brought to our notice via our own investigations many years ago. Anti-worm medicine has re-energised our interest in recent years after a well-known cancer survivor used it to cure his small-cell lung carcinoma.
As a result, a dedicated website and a Facebook group have been established to record his experience and the knowledge of other people who are benefiting from using Fenbendazole to treat cancers such as melanoma, lung and colorectal carcinoma, prostate, metastatic cancer of the pancreas and others.
These new findings simply add to the growing body of data that benzimidazole-based cancer-fighting medications may be used in combination with other treatments. Therefore, we believe that fenbendazole for humans, like mebendazole, has a strong cancer-fighting ability and hold this view and conviction.
Fenbendazole, on the other hand, has been shown to be better than mebendazole in several investigations. When it comes to battling Cryptococcus meningitis, fenbendazole was shown to be more effective than mebendazole as well as other anthelmintics, according to a research published in the Journal of Clinical Microbiology.
Fenbendazole’s cancer-fighting qualities have been the subject of several scientific studies, but this report stands out above the others, Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways, figured out that:
- “The results, in conjunction with our earlier data, suggest that Fenbendazole is a new microtubule interfering agent that displays anti-neoplastic activity and may be evaluated as a potential therapeutic agent because of its effect on multiple cellular pathways leading to the effective elimination of cancer cells.”
Proteasomal interference and microtubule function were also shown to be affected by fenbendazole, as well as the capacity to impede glucose absorption, which intrinsically starved cancer cells. The glucose transporter isoform 4 expression was lowered by fenbendazole (GLUT4). GLUT4 is transported to the plasma membrane from intracellular vesicles by insulin-stimulated glucose absorption in cells. Inhibiting GLUT4 movement by fenbendazole disrupts its linear migration across the microtubule, resulting in significantly reduced insulin-stimulated glucose absorption.
Ferbendazole, like other anti-cancer alkaloids, does not interfere with other chemotherapies since it interacts with tubulin in the same way. In this way it’s similar to colchicine. Fenbendazole and other similar compounds like sodium dichloroacetate (DCA) or berberine do not negate the cancer treating effects of surgery, radiation, and chemotherapy, as is often believed.
Fenbendazole (and related medications) may be able to reactivate the genome’s p53 gene, which is another newly released scientific article. p53 is regarded as the “Guardian of the Genome” because of its role as a tumor suppressor. Some forms of cancer, however, may compromise its capacity to limit the growth of tumors.
Fenbendazole, when paired with DCA, proved to be very successful, according to the Nature research.
Fenbendazole for humans – Is it suited for human consumption?
According to an EMEA study, “Fenbendazole for cancer in humans is well tolerated following oral exposure” (single oral dosage up to 2,000 mg/per person: 500 mg/per person for 10 consecutive days) despite its traditional and original usage in animals for the treatment of parasitic worms.
It has not yet been proven by definitive research, though. Because parasitic infections are normally eliminated within a few weeks, this is most likely owing to the drug’s nature.
In spite of this, many patients have been taking fenbendazole every day as a preventative measure to avoid cancer recurrence or as an active therapy for their malignancies. The therapy seems to be risk-free, with little, if any, adverse effects reported.
Final Note
We appreciate your visit and the time you have taken to read this content. To learn more about fenbendazole, please explore the rest of this site. We have plenty of material for you.
For those looking for additional therapy alternatives that are consistent with Fenbendazole, DCA, a metabolic anti-cancer therapeutic method, may be an option.
For more information visit: https://www.fenbendazole.org/
